Abstract
The inflammatory state, which is associated with the current pandemic of obesity, has been established as an important contributing pathogenic factor to the increased prevalence of the so-called metabolic syndrome. Many studies have focused on the contribution of various adipokines to this phenomenon, and in the present study, we provide an update on the emerging evidence that the pro-inflammatory factor, lipocalin-2, might influence various aspects of metabolic syndrome. Previous reports indicate a positive correlation of serum lipocalin-2 with fasting glucose, the homeostasis model assessment of insulin resistance index, and the inflammatory marker high-sensitivity C-reactive protein, even after adjustment for body mass index, suggesting that it is an independent risk factor for insulin resistance, diabetes, and inflammation. Direct analysis of lipocalin-2 action now also shows effects on peripheral metabolism and on cardiovascular function. A better understanding of how lipocalin-2 is regulated locally and systemically is crucial for adding to our understanding of the pathogenesis of metabolic syndrome, and to uncover potential new avenues for therapeutic approaches.
| Original language | English |
|---|---|
| Pages (from-to) | 194-199 |
| Number of pages | 6 |
| Journal | Clinical and Experimental Pharmacology and Physiology |
| Volume | 39 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 2012 Feb 1 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Physiology
- Pharmacology
- Physiology (medical)
Cite this
}
Emerging clinical and experimental evidence for the role of lipocalin-2 in metabolic syndrome. / Jang, Yangsoo; Lee, Jong Ho; Wang, Yu; Sweeney, Gary.
In: Clinical and Experimental Pharmacology and Physiology, Vol. 39, No. 2, 01.02.2012, p. 194-199.Research output: Contribution to journal › Article
TY - JOUR
T1 - Emerging clinical and experimental evidence for the role of lipocalin-2 in metabolic syndrome
AU - Jang, Yangsoo
AU - Lee, Jong Ho
AU - Wang, Yu
AU - Sweeney, Gary
PY - 2012/2/1
Y1 - 2012/2/1
N2 - The inflammatory state, which is associated with the current pandemic of obesity, has been established as an important contributing pathogenic factor to the increased prevalence of the so-called metabolic syndrome. Many studies have focused on the contribution of various adipokines to this phenomenon, and in the present study, we provide an update on the emerging evidence that the pro-inflammatory factor, lipocalin-2, might influence various aspects of metabolic syndrome. Previous reports indicate a positive correlation of serum lipocalin-2 with fasting glucose, the homeostasis model assessment of insulin resistance index, and the inflammatory marker high-sensitivity C-reactive protein, even after adjustment for body mass index, suggesting that it is an independent risk factor for insulin resistance, diabetes, and inflammation. Direct analysis of lipocalin-2 action now also shows effects on peripheral metabolism and on cardiovascular function. A better understanding of how lipocalin-2 is regulated locally and systemically is crucial for adding to our understanding of the pathogenesis of metabolic syndrome, and to uncover potential new avenues for therapeutic approaches.
AB - The inflammatory state, which is associated with the current pandemic of obesity, has been established as an important contributing pathogenic factor to the increased prevalence of the so-called metabolic syndrome. Many studies have focused on the contribution of various adipokines to this phenomenon, and in the present study, we provide an update on the emerging evidence that the pro-inflammatory factor, lipocalin-2, might influence various aspects of metabolic syndrome. Previous reports indicate a positive correlation of serum lipocalin-2 with fasting glucose, the homeostasis model assessment of insulin resistance index, and the inflammatory marker high-sensitivity C-reactive protein, even after adjustment for body mass index, suggesting that it is an independent risk factor for insulin resistance, diabetes, and inflammation. Direct analysis of lipocalin-2 action now also shows effects on peripheral metabolism and on cardiovascular function. A better understanding of how lipocalin-2 is regulated locally and systemically is crucial for adding to our understanding of the pathogenesis of metabolic syndrome, and to uncover potential new avenues for therapeutic approaches.
UR - http://www.scopus.com/inward/record.url?scp=84863030946&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84863030946&partnerID=8YFLogxK
U2 - 10.1111/j.1440-1681.2011.05557.x
DO - 10.1111/j.1440-1681.2011.05557.x
M3 - Article
C2 - 21689137
AN - SCOPUS:84863030946
VL - 39
SP - 194
EP - 199
JO - Clinical and Experimental Pharmacology and Physiology
JF - Clinical and Experimental Pharmacology and Physiology
SN - 0305-1870
IS - 2
ER -